Newsroom
In Massachusetts, Nearly 400,000 Will Seek Reinsurance
People who bought state plans instead of seeking insurance through their employer, have to go through the process again due to a temporary fix that was afforded.
Two Leading Cancer Organizations, ASCO and AACR, Take a Stand on E-Cigarettes
ASCO and AACR want to see stricter regulation of the products, touching various aspects such as flavors, child-proofing, refills etc.
Medicare Proposes Covering Newly Approved Cologuard Test for CRC Detection
The final decision on the proposal will be made only after a 30-day comment period.
"Value" Decision by NICE Met With Disapproval
Both, the scientific community and a charitable organization, Prostate Cancer UK, have criticized the drug approval body for not offering abiraterone to sufferers until after chemotherapy.
First-Ever Surgery To Replace a Failing Tricuspid Heart Valve
For the first time in the United States, doctors used a minimally invasive procedure to replace a failing, hard-to-reach heart valve with a new one – and placed it just outside the heart.
Bevacizumab Receives FDA Approval for Late-Stage Cervical Cancer
Marketed by Genentech, Avastin received priority review following encouraging safety and efficacy results.
FDA Issues Warning on Fraudulent Ebola Prevention And Treatment Products
The FDA, in a press release, has warned consumers to be aware of such products being sold online.
Employers Offer High-Deductible Plans To Save Costs
To keep their healthcare costs in check, employers are shifting the cost equation by increasing employee premiums.
Fifteen-Year Study Identifies BMI as a Risk Factor for Ten Cancers
The study, published in Lancet, reaffirms that being obese and overweight can be a major health burden and can lead to various other diseases.
Hospitals Helping Out With Premiums on Policies Bought Through Exchanges
However, insurers want the government to intervene and restrict the practice.
Ethics and Social Media—Where Do We Draw the Line?
A recent Facebook study has initiated a debate on privacy and ethicis concerns, with the Federal Trade Commission saying they'll soon be involved as well.
Amgen's Kyprolis Fails in Phase 3 MM Trial
Kyprolis failed to improve survival in the phase 3 FOCUS trial in patients who had relapse following at least 3 prior regimens.
CMS Working on a New Oncology Payment Model
CMS provided COA a draft of an episode-based payment model being developed at their Innovation Center. COA has been in collaboration with CMS on developing this model.
Lin28b Identified As a Key Gene Responsible for Childhood Cancers
The gene, normally expressed only in a developing embryo, was found expressed in several different childhood cancers.
Wikipedia—The Next WebMD?
With the aim to authenticate and regulate medical information, Cancer Research UK plans to provide the most up-to-date and accurate healthcare information.
Blood Test Could Detect DNA from Cancerous Cells: A Liquid Biopsy
Scientists at Hopkins are working on developing a test that can rapidly sequence cellular DNA in a blood sample for early diagnosis of cancer, which could have a tremendous potential in asymptomatic subtypes of the disease.
Breaking: WellPoint to Change Name to Anthem
WellPoint Inc is planning on changing its name to Anthem to eliminate brand confusion and better connect with consumers.
Reform Update: Some Question the Value of Value-Based Purchasing
Next year, U.S. healthcare providers will be subject to Medicare penalties if they do not meet up to 26 measures for value-based purchasing.
Poor Cancer Outcomes Among the Uninsured and those on Medicaid
The study, published in the Journal of Clinical Oncology, examined national statistics for the period between 2007 to 2010 for people aged 18-64 of age.
Affordable Care Act Projected to Drive Up Prescription Drug Spending in Coming Years
Specialty drugs expected to account for 40% of total prescription spending by 2016, according to Catamaran Corporation.
Cologuard Receives FDA Nod for CRC Diagnosis
Cologuard had received recommendation for premarket approval from a FDA advisory panel back in March.
Encouraging Findings on Lung Cancer Rates in the US
Although the overall rate of NSCLC is lower, certain subtypes of the disease fared better than others, the study published in the journal Cancer found.
Sovaldi's Cost-Effectiveness is Being Overplayed
Bottom line: Sovaldi will not save the system money. It will cost money—a lot of money—to reduce premature mortality due to chronic hepatitis C infection.
CMS Action Raises Questions About Accuracy of Sunshine Act Data
The CMS has removed the provider review version of a new database that details financial relationships between healthcare providers and drug and medical-device manufacturers.